56 related articles for article (PubMed ID: 19356707)
1. Antisense down regulation of connexin31.1 reduces apoptosis and increases thickness of human and animal corneal epithelia.
Chang CY; Laux-Fenton WT; Law LY; Becker DL; Sherwin T; Green CR
Cell Biol Int; 2009 Mar; 33(3):376-85. PubMed ID: 19356707
[TBL] [Abstract][Full Text] [Related]
2. Expression pattern of connexins in the corneal and limbal epithelium of a primate.
Yuan X; Chen Z; Yang Z; Gao J; Zhang A; Wu SM; Jacoby R
Cornea; 2009 Feb; 28(2):194-9. PubMed ID: 19158564
[TBL] [Abstract][Full Text] [Related]
3. Human gap junction protein connexin31: molecular cloning and expression analysis.
Wenzel K; Manthey D; Willecke K; Grzeschik KH; Traub O
Biochem Biophys Res Commun; 1998 Jul; 248(3):910-5. PubMed ID: 9704026
[TBL] [Abstract][Full Text] [Related]
4. Exchange of serine residues 263 and 266 reduces the function of mouse gap junction protein connexin31 and exhibits a dominant-negative effect on the wild-type protein in HeLa cells.
Diestel S; Eckert R; Hülser D; Traub O
Exp Cell Res; 2004 Apr; 294(2):446-57. PubMed ID: 15023533
[TBL] [Abstract][Full Text] [Related]
5. Human connexin31.9, unlike its orthologous protein connexin30.2 in the mouse, is not detectable in the human cardiac conduction system.
Kreuzberg MM; Liebermann M; Segschneider S; Dobrowolski R; Dobrzynski H; Kaba R; Rowlinson G; Dupont E; Severs NJ; Willecke K
J Mol Cell Cardiol; 2009 Apr; 46(4):553-9. PubMed ID: 19168070
[TBL] [Abstract][Full Text] [Related]
6. In vitro optimization of antisense oligodeoxynucleotide design: an example using the connexin gene family.
Law LY; Zhang WV; Stott NS; Becker DL; Green CR
J Biomol Tech; 2006 Sep; 17(4):270-82. PubMed ID: 17028167
[TBL] [Abstract][Full Text] [Related]
7. Design of ENA gapmers as fine-tuning antisense oligonucleotides with sequence-specific inhibitory activity on mouse PADI4 mRNA expression.
Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
Nucleic Acids Symp Ser (Oxf); 2006; (50):319-20. PubMed ID: 17150946
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific effects of wild-type and mutant connexin 31: a role in neurite outgrowth.
Unsworth HC; Aasen T; McElwaine S; Kelsell DP
Hum Mol Genet; 2007 Jan; 16(2):165-72. PubMed ID: 17142249
[TBL] [Abstract][Full Text] [Related]
9. Cx31.1 expression is modulated in HaCaT cells exposed to UV-induced damage and scrape-wounding.
Nugent L; Ofori-Frimpong B; Martin PE; Green CR; Wright CS
J Cell Physiol; 2021 Feb; 236(2):911-920. PubMed ID: 32592185
[TBL] [Abstract][Full Text] [Related]
10. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Cx31 is un/misfolded to cause skin abnormality via a Fos/JunB-mediated mechanism.
Tang C; Chen X; Chi J; Yang D; Liu S; Liu M; Pan Q; Fan J; Wang D; Zhang Z
Hum Mol Genet; 2015 Nov; 24(21):6054-65. PubMed ID: 26251042
[TBL] [Abstract][Full Text] [Related]
12. N-cadherin in the maintenance of human corneal limbal epithelial progenitor cells in vitro.
Higa K; Shimmura S; Miyashita H; Kato N; Ogawa Y; Kawakita T; Shimazaki J; Tsubota K
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4640-5. PubMed ID: 19420343
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial, selective and reversible control of gene expression using oligodeoxynucleotides in a cell-free protein synthesis system.
Keum JW; Ahn JH; Kang TJ; Kim DM
Biotechnol Bioeng; 2009 Feb; 102(2):577-82. PubMed ID: 18767195
[TBL] [Abstract][Full Text] [Related]
15. Sequential development of intercellular junctions in bioengineered human corneas.
González-Andrades M; Garzón I; Gascón MI; Muñoz-Avila JI; Sánchez-Quevedo MC; Campos A; Alaminos M
J Tissue Eng Regen Med; 2009 Aug; 3(6):442-9. PubMed ID: 19415764
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
17. Excitatory effects of gap junction blockers on cerebral cortex seizure-like activity in rats and mice.
Voss LJ; Jacobson G; Sleigh JW; Steyn-Ross A; Steyn-Ross M
Epilepsia; 2009 Aug; 50(8):1971-8. PubMed ID: 19486358
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of HPV-16 E6/E7 mRNA mediated by modified 10-23 deoxyribozymes.
Reyes-Gutiérrez P; Alvarez-Salas LM
Oligonucleotides; 2009 Sep; 19(3):233-42. PubMed ID: 19732021
[TBL] [Abstract][Full Text] [Related]
19. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
[TBL] [Abstract][Full Text] [Related]
20. Segment-specific expression of the gap junction gene connexin31 during hindbrain development.
Dahl E; Willecke K; Balling R
Dev Genes Evol; 1997 Nov; 207(5):359-361. PubMed ID: 27747433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
